{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T21:09:30Z","timestamp":1762376970913},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Accurate pregnancy dating is critical for maternal and child health and for counseling on safe and effective abortion methods. While last menstrual period and first trimester ultrasound are often used together to determine gestational age (GA), they have limited accuracy and availability, respectively. Prior studies have shown that pregnancy-associated plasma protein-A (PAPP-A) increases exponentially during pregnancy and has the potential to serve as a biochemical marker of GA. We aimed to analyze the relationship between sonographically determined GA and serum PAPP-A concentration measured by different immunoassays and to derive cutoff levels informative for the 70\u2009days GA commonly recommended limit for medical abortion in outpatient settings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We compared technical characteristics of 4 commercially available PAPP-A immunoassays and tested 120 maternal serum samples (GA range: 34\u2013231\u2009days) along with contrived pool samples and traceable quality controls. These characteristics included area under the receiver operator characteristic (AUROC) plot, sensitivity and specificity based on cutoffs defined by the Youden Index, and likelihood ratios.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All 4 immunoassays had sensitivities and specificities \u226580%, and AUROC values ranging from 0.948 to 0.968. Marked differences among absolute PAPP-A values were noted depending on immunoassay. PAPP-A cutoff values at 70\u2009days GA for each individual immunoassay were established along with procedural recommendations that increase equivalence among immunoassays.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Maternal serum PAPP-A levels correlated strongly with GA despite differences in immunoassay formats and absolute data output. Serum PAPP-A has biomarker potential for future development of a point-of-care test aimed at increasing access to medical abortion.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jalm\/jfab057","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T19:12:14Z","timestamp":1621969934000},"page":"1517-1532","source":"Crossref","is-referenced-by-count":6,"title":["Analytical Comparison of Pregnancy-Associated Plasma Protein-A (PAPP-A) Immunoassays for Biochemical Determination of Gestational Age"],"prefix":"10.1093","volume":"6","author":[{"given":"Irina A","family":"Buhimschi","sequence":"first","affiliation":[{"name":"Department of Obstetrics & Gynecology, University of Illinois at Chicago College of Medicine, Chicago, IL 60612"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guomao","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, University of Illinois at Chicago College of Medicine, Chicago, IL 60612"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yara","family":"El Helou","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, University of Illinois at Chicago College of Medicine, Chicago, IL 60612"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J","family":"Frye","sequence":"additional","affiliation":[{"name":"Gynuity Health Projects, New York, NY 10017"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Winikoff","sequence":"additional","affiliation":[{"name":"Gynuity Health Projects, New York, NY 10017"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth G","family":"Raymond","sequence":"additional","affiliation":[{"name":"Gynuity Health Projects, New York, NY 10017"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,7,30]]},"reference":[{"key":"2021110213152465800_jfab057-B1","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1097\/AOG.0000000000002046","article-title":"Committee opinion no 700: methods for estimating the due date","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"key":"2021110213152465800_jfab057-B2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/jog.13801","article-title":"Reliability and validity of last menstrual period for gestational age estimation in a low-to-middle-income setting","volume":"45","author":"Macaulay","year":"2019","journal-title":"J Obstet Gynaecol Res"},{"key":"2021110213152465800_jfab057-B3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0014-5793(01)02760-0","article-title":"Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A","volume":"504","author":"Laursen","year":"2001","journal-title":"FEBS Lett"},{"key":"2021110213152465800_jfab057-B4","doi-asserted-by":"crossref","first-page":"12243","DOI":"10.1016\/S0021-9258(18)31378-4","article-title":"Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein","volume":"268","author":"Oxvig","year":"1993","journal-title":"J Biol Chem"},{"key":"2021110213152465800_jfab057-B5","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/0002-9378(81)90957-1","article-title":"Pregnancy-associated plasma protein A: circulating levels during normal pregnancy","volume":"139","author":"Folkersen","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"2021110213152465800_jfab057-B6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1471-0528.1982.tb05078.x","article-title":"Amniotic fluid and plasma concentrations of pregnancy-associated plasma protein-A (PAPP-A) throughout pregnancy: comparison with other fetoplacental products","volume":"89","author":"Bischof","year":"1982","journal-title":"BJOG"},{"key":"2021110213152465800_jfab057-B7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.contraception.2020.01.007","article-title":"Sensitivity and specificity of placental proteins for gestational age screening: an exploratory study","volume":"101","author":"Raymond","year":"2020","journal-title":"Contraception"},{"key":"2021110213152465800_jfab057-B8","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e31826c315f","article-title":"Extending outpatient medical abortion services through 70 days of gestational age","volume":"120","author":"Winikoff","year":"2012","journal-title":"Obstet Gynecol"},{"key":"2021110213152465800_jfab057-B9","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/AOG.0000000000004082","article-title":"Medication abortion up to 70 days of gestation: ACOG practice bulletin, number 225","volume":"136","author":"Creinin","year":"2020","journal-title":"Obstet Gynecol"},{"key":"2021110213152465800_jfab057-B10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.semperi.2005.06.001","article-title":"First-trimester screening for chromosomal abnormalities","volume":"29","author":"Nicolaides","year":"2005","journal-title":"Semin Perinatol"},{"key":"2021110213152465800_jfab057-B11","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3109\/00016349.2010.505639","article-title":"Biology of pregnancy-associated plasma protein-A in relation to prenatal diagnostics: an overview","volume":"89","author":"Kirkegaard","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2021110213152465800_jfab057-B12","doi-asserted-by":"crossref","first-page":"21849","DOI":"10.1074\/jbc.M102191200","article-title":"Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase","volume":"276","author":"Overgaard","year":"2001","journal-title":"J Biol Chem"},{"key":"2021110213152465800_jfab057-B13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0001-2998(78)80014-2","article-title":"Basic principles of ROC analysis","volume":"8","author":"Metz","year":"1978","journal-title":"Semin Nucl Med"},{"key":"2021110213152465800_jfab057-B14","first-page":"S49","article-title":"Limit of blank, limit of detection and limit of quantitation","volume":"29(Suppl 1","author":"Armbruster","year":"2008","journal-title":"Clin Biochem Rev"},{"key":"2021110213152465800_jfab057-B15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/aje\/kwj063","article-title":"The inconsistency of \"optimal\" cutpoints obtained using two criteria based on the receiver operating characteristic curve","volume":"163","author":"Perkins","year":"2006","journal-title":"Am J Epidemiol"},{"key":"2021110213152465800_jfab057-B16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"2021110213152465800_jfab057-B17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"2021110213152465800_jfab057-B18","first-page":"709","article-title":"Bablok A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I","volume":"21","author":"Passing","year":"1983","journal-title":"J Clin Chem Clin Biochem"},{"key":"2021110213152465800_jfab057-B19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/clinchem\/48.3.473","article-title":"Point-of-care time-resolved immunofluorometric assay for human pregnancy-associated plasma protein A: use in first-trimester screening for Down syndrome","volume":"48","author":"Qin","year":"2002","journal-title":"Clin Chem"},{"key":"2021110213152465800_jfab057-B20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/bioinformatics\/bty537","article-title":"Multiomics modeling of the immunome, transcriptome, microbiome, proteome and metabolome adaptations during human pregnancy","volume":"35","author":"Ghaemi","year":"2019","journal-title":"Bioinformatics"},{"key":"2021110213152465800_jfab057-B21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/14737159.2018.1412258","article-title":"Selecting analytical biomarkers for diagnostic applications: a first principles approach","volume":"18","author":"Byrnes","year":"2018","journal-title":"Expert Rev Mol Diagn"},{"key":"2021110213152465800_jfab057-B22","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1469-0691.2010.03280.x","article-title":"Economic evaluation of point-of-care diagnostic technologies for infectious diseases","volume":"16","author":"Loubiere","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"2021110213152465800_jfab057-B23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/uog.22140","article-title":"Screening for trisomy at 11-13 weeks\u2019 gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both","volume":"56","author":"Mazer Zumaeta","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2021110213152465800_jfab057-B24","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/uog.22093","article-title":"Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both","volume":"56","author":"Mazer Zumaeta","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2021110213152465800_jfab057-B25","doi-asserted-by":"crossref","first-page":"e0159592","DOI":"10.1371\/journal.pone.0159592","article-title":"Pregnancy associated plasma protein-A and placental growth factor in a Sub-Saharan African population: a nested cross-sectional study","volume":"11","author":"Browne","year":"2016","journal-title":"PLoS ONE"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jalm\/article-pdf\/6\/6\/1517\/41046748\/jfab057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jalm\/article-pdf\/6\/6\/1517\/41046748\/jfab057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T04:36:40Z","timestamp":1699072600000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/6\/6\/1517\/6331364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,30]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,7,30]]},"published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfab057","relation":{},"ISSN":["2576-9456","2475-7241"],"issn-type":[{"value":"2576-9456","type":"print"},{"value":"2475-7241","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2021,7,30]]}}}